Talk Pharmacovigilance & Safety track
S0702 - Real World Data Access and Availability: Actions to Accelerate Answers in Pharmacovigilance
Tue, Mar 18, 2025 · 3:10–4:20 PM CET Sydney Room, Congress Center Basel
About this session
Explore how real-world data can revolutionize pharmacovigilance practices through enhanced collaboration between industry, regulators, and academics. The session will delve into improving access and availability of real-world data to address critical safety questions. Discussions will cover the future of vigilance through real-world evidence and strategies for meeting regulatory expectations while enhancing global patient safety. Attendees will gain insights into the effective use of real-world data in post-marketing safety efforts.
Programme:
- 2. Real World Data Access and Availability: Actions to Accelerate Answers in Pharmacovigilance — William Blumentals
- 1. EU Scene Setting — Patrice Verpillat
- 4. Future of Vigilance and Real World Evidence — Kendal Harrison
- 3. Post-marketing Safety: Using Real-World Evidence to Satisfy Regulatory Expectations and Inform Patient Safety Globally — Marieke Schoonen
- Panel Discussion
